These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9339477)

  • 1. A toxicologically based weight-of-evidence methodology for the relative ranking of chemicals of endocrine disruption potential.
    Calabrese EJ; Baldwin LA; Kostecki PT; Potter TL
    Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 1):36-40. PubMed ID: 9339477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine disruptor risk characterization: an EPA perspective.
    Fenner-Crisp PA
    Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 1):70-3. PubMed ID: 9339482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproducibility of endocrine disruption data.
    Ashby J; Elliott BM
    Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 1):94-5. PubMed ID: 9339485
    [No Abstract]   [Full Text] [Related]  

  • 4. Vulnerability of the endocrine system to xenobiotic influence.
    Neubert D
    Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 1):9-29. PubMed ID: 9339474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adrenal cortex and steroidogenesis as cellular and molecular targets for toxicity: critical omissions from regulatory endocrine disrupter screening strategies for human health?
    Harvey PW; Everett DJ
    J Appl Toxicol; 2003; 23(2):81-7. PubMed ID: 12666151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond screening: problems and prospects for risk characterization of endocrine disruptors.
    Rhomberg L
    Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 1):74-9. PubMed ID: 9339483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction: neurobiological impact of environmental estrogens.
    Panzica GC; Viglietti-Panzica C; Ottinger MA
    Brain Res Bull; 2005 Apr; 65(3):187-91. PubMed ID: 15811580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An assessment of endocrine disruption in mollusks and the potential for developing internationally standardized mollusk life cycle test guidelines.
    Matthiessen P
    Integr Environ Assess Manag; 2008 Jul; 4(3):274-84. PubMed ID: 18393578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine disruptors in marine organisms: approaches and perspectives.
    Porte C; Janer G; Lorusso LC; Ortiz-Zarragoitia M; Cajaraville MP; Fossi MC; Canesi L
    Comp Biochem Physiol C Toxicol Pharmacol; 2006 Jul; 143(3):303-15. PubMed ID: 16723279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals.
    Lill MA; Winiger F; Vedani A; Ernst B
    J Med Chem; 2005 Sep; 48(18):5666-74. PubMed ID: 16134935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitellogenin synthesis in primary cultures of fish liver cells as endpoint for in vitro screening of the (anti)estrogenic activity of chemical substances.
    Navas JM; Segner H
    Aquat Toxicol; 2006 Oct; 80(1):1-22. PubMed ID: 16950525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can farm animals help to study endocrine disruption?
    Magnusson U
    Domest Anim Endocrinol; 2005 Aug; 29(2):430-5. PubMed ID: 15885963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicogenomic approach to endocrine disrupters: identification of a transcript profile characteristic of chemicals with estrogenic activity.
    Naciff JM; Daston GP
    Toxicol Pathol; 2004; 32 Suppl 2():59-70. PubMed ID: 15503665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitive detection of the endocrine effects of the estrogen analogue ethinylestradiol using a modified enhanced subacute rat study protocol (OECD Test Guideline no. 407).
    Andrews P; Freyberger A; Hartmann E; Eiben R; Loof I; Schmidt U; Temerowski M; Folkerts A; Stahl B; Kayser M
    Arch Toxicol; 2002 May; 76(4):194-202. PubMed ID: 12029382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of evidence: are endocrine-disrupting chemicals in the aquatic environment impacting fish populations?
    Mills LJ; Chichester C
    Sci Total Environ; 2005 May; 343(1-3):1-34. PubMed ID: 15862833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are brominated flame retardants endocrine disruptors?
    Legler J; Brouwer A
    Environ Int; 2003 Sep; 29(6):879-85. PubMed ID: 12850103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the structural diversity of data sets on the statistical quality of three-dimensional quantitative structure-activity relationship (3D-QSAR) models: predicting the estrogenic activity of xenoestrogens.
    Yu SJ; Keenan SM; Tong W; Welsh WJ
    Chem Res Toxicol; 2002 Oct; 15(10):1229-34. PubMed ID: 12387618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zebrafish (Danio rerio) as a model organism for investigating endocrine disruption.
    Segner H
    Comp Biochem Physiol C Toxicol Pharmacol; 2009 Mar; 149(2):187-95. PubMed ID: 18955160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-response relationships for endocrine disruptors: what we know and what we don't know.
    Lucier GW
    Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 1):34-5. PubMed ID: 9339476
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.